tiprankstipranks
Trending News
More News >
PharmaSGP Holding SE (DE:PSG)
HAMBURG:PSG
Germany Market
Advertisement

PharmaSGP Holding SE (PSG) Price & Analysis

Compare
7 Followers

PSG Stock Chart & Stats


PSG FAQ

What was PharmaSGP Holding SE’s price range in the past 12 months?
PharmaSGP Holding SE lowest stock price was €22.00 and its highest was €31.40 in the past 12 months.
    What is PharmaSGP Holding SE’s market cap?
    PharmaSGP Holding SE’s market cap is €369.60M.
      When is PharmaSGP Holding SE’s upcoming earnings report date?
      PharmaSGP Holding SE’s upcoming earnings report date is Nov 27, 2025 which is in 54 days.
        How were PharmaSGP Holding SE’s earnings last quarter?
        PharmaSGP Holding SE released its earnings results on Sep 25, 2025. The company reported €0.289 earnings per share for the quarter, beating the consensus estimate of N/A by €0.289.
          Is PharmaSGP Holding SE overvalued?
          According to Wall Street analysts PharmaSGP Holding SE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does PharmaSGP Holding SE pay dividends?
            PharmaSGP Holding SE pays a Annually dividend of €0.05 which represents an annual dividend yield of 0.16%. See more information on PharmaSGP Holding SE dividends here
              What is PharmaSGP Holding SE’s EPS estimate?
              PharmaSGP Holding SE’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does PharmaSGP Holding SE have?
              PharmaSGP Holding SE has 12,000,000 shares outstanding.
                What happened to PharmaSGP Holding SE’s price movement after its last earnings report?
                PharmaSGP Holding SE reported an EPS of €0.289 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.654%.
                  Which hedge fund is a major shareholder of PharmaSGP Holding SE?
                  Currently, no hedge funds are holding shares in DE:PSG

                  PharmaSGP Holding SE Stock Smart Score

                  Company Description

                  PharmaSGP Holding SE

                  PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

                  PharmaSGP Holding SE (PSG) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Medios AG
                  SynBiotic SE
                  APONTIS PHARMA AG
                  MPH Health Care AG
                  M1 Kliniken AG

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis